TAC 300 Tablet is a high-strength oral antifungal medication containing Fluconazole 300 mg as its active pharmaceutical ingredient. Fluconazole is a synthetic triazole compound known for its potent and broad-spectrum activity against various fungal pathogens. TAC 300 is designed for use in conditions that require a higher dose or extended antifungal therapy, such as recurrent vaginal yeast infections, systemic candidiasis, and deep fungal infections of internal organs.

Fluconazole works by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase, which is essential for the conversion of lanosterol to ergosterol, a critical component of the fungal cell membrane. The depletion of ergosterol weakens the fungal cell wall, leading to cell death. This mechanism allows TAC 300 to be effective against Candida species, Cryptococcus neoformans, and various dermatophytes.

TAC 300 Tablet is typically prescribed in weekly regimens or as part of long-term antifungal management. It is especially beneficial for patients with chronic or relapsing infections who need sustained antifungal coverage with convenient dosing. This higher dose option is also used in onychomycosis (fungal nail infections), where long treatment durations are often required for effective nail penetration and fungal eradication.

Produced under rigorous pharmaceutical standards by Bluepill Express, TAC 300 Tablet complies with WHO-GMP and ISO-certified manufacturing protocols. The product is formulated for high oral bioavailability, ensuring consistent plasma levels and effective therapeutic action. Its manufacturing process guarantees purity, potency, and microbiological safety, backed by detailed quality documentation.

Bluepill Express offers end-to-end third-party manufacturing solutions for TAC 300, supporting branding, packaging customization, and compliance with global regulatory requirements. The product is packed in moisture-resistant blister strips to maintain tablet integrity and extend shelf life. Full regulatory documentation such as Certificate of Analysis, MSDS, and CTD Dossier is available to support market registration and export processes.

TAC 300 Tablet is especially valuable in hospital and outpatient settings where advanced antifungal treatment is necessary. With growing concerns about resistant fungal infections and the need for long-term therapy in immunocompromised populations, TAC 300 plays a vital role in antifungal stewardship. It offers clinicians and patients a convenient, effective, and well-tolerated solution for managing complex fungal diseases.